


The Fund aims to achieve long term capital growth.
| Name | % Net Assets |
|---|---|
| General Electric Co. | 2.7% |
| Bank of America Corp. | 2.7% |
| Sanofi-Synthelabo | 2.7% |
| Pfizer Inc. | 2.3% |
| France Telecom | 1.9% |
| J.P. Morgan Chase & Co. | 1.8% |
| Occidental Petroleum Corp. | 1.8% |
| Microsoft Corp. | 1.8% |
| Credit Suisse Group | 1.7% |
| OCCIDENTAL PETROLEUM CORP | 1.7% |
| Key | % Net Assets |
|---|---|
| 2.7% | |
| 2.7% | |
| 2.7% | |
| 2.3% | |
| 89.6% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | $23.46 |
| Currency | USD |
| Change | $-0.19 |
| % | -0.81% |
| YTD change | $3.85 |
| YTD % | 19.64% |
| Fund Inception | 14/02/1994 |
|---|---|
| Fund Manager | Mark Breedon / James Hand / Sandi Merwitz |
| TER | 1.62 (31-Dec-2011) |
| Minimum Investment | |
|---|---|
| Initial | $100000 |
| Additional | $500 |
| Savings | $100 |
| Charges | |
|---|---|
| Initial | 4.50% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.12 |
You are here: research